In The News, Newsroom

Tessa Longbons at RealClearHealth: Suppressing Science

Six boxes of Mifepristone Tablets, 200 mg, are stacked in two rows. The boxes display dosage information, prescription labeling, and a logo on a white and purple background—an image at the center of debates about suppressing science.

On January 29, the Supreme Court scheduled oral arguments to be held in March for Alliance for Hippocratic Medicine v. FDA, a case challenging decisions by the FDA to eliminate key regulations of the abortion drug mifepristone. Just one week later, a key study on mifepristone safety – which I coauthored – was retracted.

Keep reading at RealClearHealth >>

Back to Press Releases
Pregnant?

Pregnant? Need help?